|
| |
 |
 #INTHEAIREVERYWHERE |
| Vol. 19 No. 67 | Tuesday
October 13, 2020 |
 |
|
|
| If you have any words you’d like to share, any of your own playlists you’d like us to help distribute, or other content that has helped you navigate this difficult time, please share them with us. Air Cargo News FlyingTypers hopes to be like an online hearth for our cargo family. #AirCargoCoronaContent |
|
 |
Throughout modern history in general, and this pandemic crisis in particular, air cargo has played a vital role in the delivery of critical supplies and equipment on a global basis. As the pharmaceutical industry dedicates its resources to the creation of an effective vaccine, one of the greatest challenges will be the design and implementation of an efficient distribution system that will address the demanding logistical requirements. Airports and their partners will be critical elements in the planning and operations. There are obvious variables that must be addressed. The originating distribution points still need to be determined - the success of the pharma companies in developing an approved vaccine, and their locations, will be the deciding factors. However, the ultimate distribution systems and delivery points will be theoretically predicated upon a number of measurable and weighted criteria which could include (but not be limited to) in an order to be determined: • Population concentration • Regional infection rates • Concentration of specific societal and industry elements • Essential workers and businesses • Schools and educational facilities • Concentration of population with high pre-morbidity • Local distribution operational capacity • Regional distribution facilities and infrastructure At this point in time, the primary distribution targets and relevant networks should have been determined with the priorities being the remaining key variable issue. Assuming that is the case, then the mechanisms should be in place to ensure that the latter criteria, which are directly relevant to airports and their partners, are in motion. When a vaccine is fully confirmed as viable, demand will be enormous. In all probability, assuming the production of the vaccine is ramped up to maximum levels, the manufacturing facility (or facilities) will create extremely high volumes of the product (and demand for related equipment) which will stress unprepared distribution facilities and infrastructure. There are questions to be addressed including who will be responsible for each aspect of the project? Have the main distribution points been identified? Were critical players in the logistics chain involved in the process? Also, is the transportation infrastructure prepared? The challenges that will be faced could be significant - particularly if there are multiple States and jurisdictions in a single targeted region. Putting aside the administrative issues for a moment, there are a number of primary considerations which will vary based on the targeted regions. • The establishment of regional control and communications centers and the creation of a planned distribution network. This will be a vital link in the chain. • Once distribution has begun, shippers, airports, carriers, forwarders, customs brokers, trucking companies, federal and local agencies, local distribution centers, and the ultimate sites for vaccine administration must work closely together in real time. • The availability of federal staff to ensure inspection and clearance of shipments on a timely basis. • The capacity of the aircraft apron to accommodate inbound and outbound freighters and the availability of necessary handling equipment • Possible trucking access directly to the aircraft apron • The availability of staff to coordinate and prioritize apron movements • The availability of climate-controlled facilities for inbound and outbound shipments • Designation of high-speed throughput or bypass lanes in the air cargo facility. • Trucks with climate-control capacity • Designated and prepared landside consolidation and distribution facilities • Designated and prepared facilities for the administration of the vaccine • Establishment of controls for landside access and queuing • Creation of security protocols for the transport and storage of the vaccine As in so many of the challenges we face, timing is critical – tomorrow will be pushing the envelope. The logistics of the distribution operation are daunting – but manageable. Success will depend on comprehensive and early planning, close and on-going communication, and perhaps most importantly, management that understands the issues and commits 100% to implementation. Dan Muscatello
|
Last month The New York Times reported that some COVID-19 vaccines may have to be shipped at temperatures as low as minus 80 degrees F, raises the thought that the challenge of getting the life-saving serums could be infinitely more complex than originally believed. But before we spin ourselves into another “can we deliver?” frenzy, we think a bit of level-headed look about is in order. At arm’s length may be some solutions, including as example, a company out there called Coldco Frozen Fulfillment Solutions. St. Louis Coldco 3PL with a can-do attitude offers a complete menu on a web page vision statement that features a nice picture of the Swiss Alps, an impression that is cold enough for us. “We will store your products at the required temperature, then as orders are received they are picked, packed, and shipped according to your specifications,” Coldco declares. Coldco promises that it can reach 70% of the United States population in 48 hours or less, utilizing ground service shipping. “More than 105 million tons of cargo passes through the St. Louis area annually between the four major interstates with national access, six Class I railroad terminals, four inland ports, and five airports including two international cargo airports,” Coldco said. “With the addition of our Reno, NV warehouse in 2019, the Coldco Logistics network can reach 97% of the U.S. population in 1-2 days using ground shipping.” For more click here. |
 |
 No Masking It . . . From Rio to Timbuktu, this scene is being repeated (with proper masks we hope) as the world receives H1N1 vaccinations against Swine Flu. While medicine fights the flu, researchers are desperately seeking the magic bullet that will mitigate COVID -19. Pease wear a mask is the message here. |
|
We heard on the radio that soon travelers
could be tested for COVID-19 before boarding a flight and then after landing
whilst travelling between New York City and London. |
If
You Missed Any Of The Previous 3 Issues Of FlyingTypers Access complete issue by clicking on issue icon or Access specific articles by clicking on article title |
||
 Vol. 19 No. 64 Why CNS Partnership? Letters to the Editor Will IATA take CNS down? |
|
|
Publisher-Geoffrey Arend
• Managing Editor-Flossie Arend • Editor Emeritus-Richard
Malkin Film Editor-Ralph Arend • Special Assignments-Sabiha Arend, Emily Arend |
Send comments and news to geoffrey@aircargonews.com
|
One
very concerned individual in all of this is Airforwarder Association President
Brandon Fried. In fact, we also spoke to Jenni Latham Frigger, (left)
VP Sales & Marketing of EMO Trans Logistics who serves as a member
of the AfA board and here is what they said.
“The CNS Partnership Conference has
been a noteworthy event since its inception, and Airforwarders Association
members have participated in all of them. 
Air
Cargo News FlyingTypers reserves the right to edit all submissions
for length and content. All photos and written material submitted to
this publication become the property of All Cargo Media.
100%
Green